Bulldog Investors’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Bulldog Investors’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-53,793	Closed	-$3K	–	142
2020 Q1	$3K	Sell	53,793 -16,308	-23%	-$1.97K	﹤0.01%	141
2019 Q4	$11K	Hold	70,101	–	–	﹤0.01%	146
2019 Q3	$12K	Sell	70,101 -42,620	-38%	-$8.31K	0.01%	144
2019 Q2	$25	Sell	112,721 -8,000	-7%	-$1.42K	0.01%	142
2019 Q1	$22K	Sell	120,721 -22,410	-16%	-$5.65K	0.01%	133
2018 Q4	$85K	Buy	143,131 +21,050	+17%	+$7.29K	0.03%	112
2018 Q3	$47K	Hold	122,081	–	–	0.01%	116
2018 Q2	$45K	Sell	122,081 -2,919	-2%	-$1.34K	0.01%	114
2018 Q1	$41K	Buy	+125,000	New	+$49.1K	0.01%	112

Other funds holding NRXPW

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

VAS

VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Bulldog Investors's NRXPW Position: Q2 2020 in Review

Bulldog Investors sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q2 2020, closing a stake of 53,793 shares — an estimated $3K sold.

Bulldog Investors first reported a position in NRXPW in Q1 2018 and held it in 9 quarters. The position peaked at $85K in Q4 2018. 13 funds tracked by Wall St. Rank hold NRXPW as of Q2 2020.

Bulldog Investors reported no remaining NRX Pharmaceuticals Warrant position as of Q2 2020 after selling out during the quarter.
Bulldog Investors sold 53,793 NRX Pharmaceuticals Warrant shares in Q2 2020, an estimated $3K.
Bulldog Investors first reported a position in NRX Pharmaceuticals Warrant in Q1 2018 and held it in 9 quarters.
Bulldog Investors's NRX Pharmaceuticals Warrant position peaked at $85K in Q4 2018.
13 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2020.

Based on Bulldog Investors's 13F filing for Q2 2020, filed 13 Aug 2020.